Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...

The stock has lagged behind the Dow over the longer term as well. ELV stock has declined 16.7% on a YTD basis and 18.5% over the past 52 weeks compared to DOWI’s 18.8% gains in 2024 and 23.9% ...

Health-care companies rose sharply amid strong earnings. Elevance Health, the health insurer formerly known as Anthem, posted fourth-quarter profit and revenue ahead of Wall Street targets ...

S&P 500 notches closing record with focus on Trump comments, earnings January 24, 2025 Elevance Health on Thursday ... survey finds The Dow Jones Industrial Average and S&P 500 chalked up record ...

Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an ...

Ryan Langston has given his Buy rating due to a combination of factors influencing Elevance ... Universal Health, and Addus Homecare. According to TipRanks, Langston has an average return of ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...